1. Home
  2. NVAX vs CRI Comparison

NVAX vs CRI Comparison

Compare NVAX & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.73

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$32.07

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
CRI
Founded
1987
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1995
2003

Fundamental Metrics

Financial Performance
Metric
NVAX
CRI
Price
$6.73
$32.07
Analyst Decision
Hold
Sell
Analyst Count
9
4
Target Price
$10.78
$29.50
AVG Volume (30 Days)
4.2M
986.0K
Earning Date
11-06-2025
10-27-2025
Dividend Yield
N/A
3.17%
EPS Growth
N/A
N/A
EPS
2.07
2.45
Revenue
$1,064,651,000.00
$2,832,687,000.00
Revenue This Year
$58.91
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
$3.19
$12.86
Revenue Growth
20.27
N/A
52 Week Low
$5.01
$23.38
52 Week High
$11.55
$58.13

Technical Indicators

Market Signals
Indicator
NVAX
CRI
Relative Strength Index (RSI) 41.74 54.81
Support Level $6.56 $31.00
Resistance Level $7.03 $32.44
Average True Range (ATR) 0.26 1.34
MACD 0.05 0.08
Stochastic Oscillator 49.78 67.02

Price Performance

Historical Comparison
NVAX
CRI

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: